{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T08:56:33Z","timestamp":1768467393047,"version":"3.49.0"},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,20]]},"abstract":"<jats:p>Quality of life has not been well-explored in patients hospitalized with morbilliform drug eruptions. We found that morbilliform drug eruptions impacted patients across six major domains: impact on other medical conditions, self-image, medical distrust, impact on diet, mental health and physical symptoms. Dermatologists and other healthcare providers should remain cognizant of the impacted domains in the counselling and management of this patient population.<\/jats:p>","DOI":"10.1093\/bjd\/ljaf072","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T03:54:23Z","timestamp":1740455663000},"page":"169-171","source":"Crossref","is-referenced-by-count":2,"title":["Impact of morbilliform drug eruptions on health-related quality of life: a qualitative analysis"],"prefix":"10.1093","volume":"193","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8418-8893","authenticated-orcid":false,"given":"Allison","family":"Yan","sequence":"first","affiliation":[{"name":"The Ohio State University College of Medicine , Columbus, OH ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Gallardo","sequence":"additional","affiliation":[{"name":"The Ohio State University College of Medicine , Columbus, OH ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cole","family":"Veliky","sequence":"additional","affiliation":[{"name":"The Ohio State University College of Medicine , Columbus, OH ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"McFeeters","sequence":"additional","affiliation":[{"name":"The Ohio State University College of Medicine , Columbus, OH ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelsey","family":"Nusbaum","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center, Department of Dermatology , Columbus, OH ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Johnson","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center, Department of Dermatology , Columbus, OH ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristopher","family":"Fisher","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center, Department of Dermatology , Columbus, OH ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Korman","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center, Department of Dermatology , Columbus, OH ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8079-0011","authenticated-orcid":false,"given":"Benjamin","family":"Kaffenberger","sequence":"additional","affiliation":[{"name":"The Ohio State University Wexner Medical Center, Department of Dermatology , Columbus, OH ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"key":"2025062500033760600_ljaf072-B1","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.arcmed.2006.03.010","article-title":"Epidemiology of adverse cutaneous drug reactions. A prospective study in hospitalized patients","volume":"37","author":"Hern\u00e1ndez-Salazar","year":"2006","journal-title":"Arch Med Res"},{"key":"2025062500033760600_ljaf072-B2","doi-asserted-by":"crossref","first-page":"e319-20","DOI":"10.1111\/ijd.16249","article-title":"Drug eruptions are associated with increased length of stay in hospitalized patients with sepsis","volume":"62","author":"Gallardo","year":"2023","journal-title":"Int J Dermatol"},{"key":"2025062500033760600_ljaf072-B3","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.jaad.2017.12.031","article-title":"Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients","volume":"78","author":"Phillips","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"2025062500033760600_ljaf072-B4","first-page":"59","article-title":"Defining drugs that are high-risk associations for drug reactions within the hospital setting","volume":"15","author":"Gilkey","year":"2022","journal-title":"J Clin Aesthet Dermatol"},{"key":"2025062500033760600_ljaf072-B5","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"2025062500033760600_ljaf072-B6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1034\/j.1600-0560.2001.028003113.x","article-title":"Acute generalized exanthematous pustulosis (AGEP) \u2013 a clinical reaction pattern","volume":"28","author":"Sidoroff","year":"2001","journal-title":"J Cutan Pathol"},{"key":"2025062500033760600_ljaf072-B7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.nedt.2003.10.001","article-title":"Qualitative content analysis in nursing research: concepts, procedures and measures to achieve trustworthiness","volume":"24","author":"Graneheim","year":"2004","journal-title":"Nurse Educ Today"},{"key":"2025062500033760600_ljaf072-B8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/ijd.14703","article-title":"The frequency of low-risk morbilliform drug eruptions observed in patients treated with different classes of antibiotics","volume":"59","author":"Krispinsky","year":"2020","journal-title":"Int J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf072\/62132202\/ljaf072.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/1\/169\/62132202\/ljaf072.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/193\/1\/169\/62132202\/ljaf072.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T04:03:46Z","timestamp":1750824226000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/193\/1\/169\/8038596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":8,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,2,25]]},"published-print":{"date-parts":[[2025,6,20]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf072","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,2,25]]}}}